ProFunds Biotechnology UltraSector Fund (BIPSX)
| Fund Assets | 108.25M |
| Expense Ratio | 2.52% |
| Min. Investment | $5,000 |
| Turnover | 52.00% |
| Dividend (ttm) | 0.02 |
| Dividend Yield | 0.06% |
| Dividend Growth | -99.85% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 19, 2025 |
| Previous Close | 51.89 |
| YTD Return | 48.77% |
| 1-Year Return | 150.34% |
| 5-Year Return | -0.60% |
| 52-Week Low | 20.79 |
| 52-Week High | 52.31 |
| Beta (5Y) | 1.24 |
| Holdings | 157 |
| Inception Date | Jun 19, 2000 |
About BIPSX
ProFunds Biotechnology UltraSector Fund Service Class is a leveraged mutual fund designed to deliver daily investment results that correspond to one and one-half times (1.5x) the daily performance of the S&P Biotechnology Select Industry Index. This fund employs derivatives and other financial instruments to amplify exposure to the U.S. biotechnology sector, making it suitable for investors seeking focused, short-term trades on biotech market movements. The fund is non-diversified and includes holdings from companies engaged primarily in biotechnology, with significant positions in both leading biotech firms and major financial counterparties to support its leveraged strategy. As a passively managed fund, it tracks its target index closely but with increased volatility and risk due to its leverage. The ProFunds Biotechnology UltraSector Fund Service Class plays a specialized role in the market by providing tactical access to the biotechnology industry, allowing investors to express strong convictions about short-term sector performance or to hedge broader portfolios with a targeted, amplified biotech allocation.
Performance
BIPSX had a total return of 150.34% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.32%.
Other Share Classes
These are alternative share classes of the same fund, from the same provider.
| Symbol | Share Class | Expense Ratio |
|---|---|---|
| BIPIX | Investor Class | 1.52% |
Top 10 Holdings
35.62% of assets| Name | Symbol | Weight |
|---|---|---|
| HSBC SECURITIES (USA), INC. B 3.5 , 5/01/2026 | n/a | 8.47% |
| SOCIETE' GENERALE 3.52 , 5/01/2026 | n/a | 7.20% |
| CF Secured 3.52 , 5/01/2026 | n/a | 6.36% |
| NATWEST MARKETS PLC 3.51 , 5/01/2026 | n/a | 4.24% |
| UMB FINANCIAL CORP. 3.37 , 5/01/2026 | n/a | 2.11% |
| Short-Term Investment Trust - Invesco Government & Agency Portfolio | AGPXX | 2.05% |
| ROYAL BANK OF CANADA 3.42 , 5/01/2026 | n/a | 1.48% |
| Apellis Pharmaceuticals, Inc. | APLS | 1.35% |
| Revolution Medicines, Inc. | RVMD | 1.19% |
| Travere Therapeutics, Inc. | TVTX | 1.17% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2025 | $0.01967 | Dec 22, 2025 |
| Dec 27, 2024 | $13.04498 | Dec 30, 2024 |
| Dec 20, 2023 | $4.12801 | Dec 21, 2023 |
| Dec 21, 2020 | $8.0736 | Dec 21, 2020 |
| Dec 23, 2019 | $2.02988 | Dec 23, 2019 |
| Dec 27, 2018 | $2.86745 | Dec 27, 2018 |